Catalyst Wire Dossier Catalyst Wire Dossier

Aldosterone-hybrid Steroid

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aldosterone-hybrid Steroid, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA) [NA]

See pricing